Literature DB >> 26787566

Plasma neutrophil gelatinase-associated lipocalin as a marker for the prediction of worsening renal function in children hospitalized for acute heart failure.

Sahar Elsharawy, Lila Raslan, Saed Morsy1, Basheir Hassan, Naglaa Khalifa.   

Abstract

Acute heart failure (AHF) is frequently associated with worsening renal function in adult patients. Neutrophil gelatinase-associated lipocalin (NGAL) serves as an early marker for acute renal tubular injury. To assess the role of plasma NGAL in predicting worsening renal function (WRF) in children with AHF, we studied 30 children hospitalized for AHF; children with history of chronic renal disease or on nephrotoxic drugs were excluded. Twenty age- and sex-matched healthy children were included in the study as a control group. Echocardiographic examination was performed on admission. Blood urea nitrogen (BUN), serum creatinine, estimated glomerular filtration rate (eGFR) and plasma NGAL levels were measured on admission and 72 h later. Seventeen (56.6%) patients developed WRF within the three-day follow-up period. At presentation, plasma NGAL level was significantly elevated in children who developed WRF. Admission plasma NGAL level correlated with renal parameters (BUN, creatinine and eGFR) as well as with left ventricular systolic parameters (ejection fraction and fractional shortening). For prediction of WRF, admission plasma, NGAL level>27.5 μg/L had sensitivity and specificity of 90% and 68%, respectively. The area under the receiver-operator curve was higher for NGAL (0.869) than for BUN (0.569) or eGFR (0.684). We conclude that admission plasma NGAL level can predict WRF in children hospitalized for AHF.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26787566     DOI: 10.4103/1319-2442.174071

Source DB:  PubMed          Journal:  Saudi J Kidney Dis Transpl        ISSN: 1319-2442


  4 in total

1.  Accuracy of neutrophil gelatinase-associated lipocalin for acute kidney injury diagnosis in children: systematic review and meta-analysis.

Authors:  Luís Taddeo Filho; Antonio Jose Grande; Tamy Colonetti; Éverton Simon Possamai Della; Maria Inês da Rosa
Journal:  Pediatr Nephrol       Date:  2017-06-14       Impact factor: 3.714

Review 2.  Lipocalin 2 (LCN2) Expression in Hepatic Malfunction and Therapy.

Authors:  Anastasia Asimakopoulou; Sabine Weiskirchen; Ralf Weiskirchen
Journal:  Front Physiol       Date:  2016-09-27       Impact factor: 4.566

3.  Impact of renal dysfunction on the management and outcome of acute heart failure: results from the French prospective, multicentre, DeFSSICA survey.

Authors:  Dominique Dos Reis; Laurie Fraticelli; Adrien Bassand; Stéphane Manzo-Silberman; Nicolas Peschanski; Sandrine Charpentier; Meyer Elbaz; Dominique Savary; Eric Bonnefoy-Cudraz; Said Laribi; Patrick Henry; Abdallah Guerraoui; Karim Tazarourte; Tahar Chouihed; Carlos El Khoury
Journal:  BMJ Open       Date:  2019-01-15       Impact factor: 2.692

Review 4.  Pharmacologic and interventional paradigms of diuretic resistance in congestive heart failure: a narrative review.

Authors:  Simge Acar; Sueda Sanli; Cinar Oztosun; Baris Afsar; Alan A Sag; Masanari Kuwabara; Adrian Covic; Alberto Ortiz; Mehmet Kanbay
Journal:  Int Urol Nephrol       Date:  2021-01-03       Impact factor: 2.370

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.